| PUBCHEM ID |
119057994
|
| UNII |
02EX089MEU
|
| Preferred Term |
BIS (1-((1-((1-HYDROPEROXY-1-METHYLPROPYL)DIOXY)-1-METHYLPROPYL)DIOXY)-1-METHYLPROPYL)PEROXIDE
|
| CAS |
91795-84-5
|
| INCHIKEY |
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CC[C@@](C)(OO)OO[C@](C)(CC)OO[C@](C)(CC)OO[C@@](C)(CC)OO[C@@](C)(CC)OO[C@@](C)(CC)OO
|
| Total Surface Area |
438,34
|
| Relative PSA |
0,33353
|
| TPSA |
151,22
|
| cLogS |
-6,258
|
| MW |
562,647
|
| cLogP |
8,6406
|
| H-Acceptors |
14
|
| H-Donors |
2
|
| Ro5 violations |
3
|
| Druglikeness |
-7,4384
|
| DrugScore |
2,38302115165405E-02
|
| Mutagenic |
low
|
| Tumorigenic |
high
|
| Reproductive Effective |
high
|
| Irritant |
low
|
| Blood-Brain Barrier |
BBB+
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
-0,0802
|
| P-glycoprotein Substrate |
Non-substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Non-substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Carcinogens
|
| Fish Toxicity I |
Low FHMT
|
| Fish Toxicity II |
2,6223
|
| Tetrahymena Pyriformis Toxicity I |
Low TPT
|
| Tetrahymena Pyriformis Toxicity II |
-0,8807
|
| Tetrahymena Pyriformis Toxicity |
High HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,0058
|
| Carcinogenicity (Three-class) |
Non-required
|
